US Stock MarketDetailed Quotes

PRAX Praxis Precision Medicines

Watchlist
  • 36.210
  • -2.290-5.95%
Close Mar 10 16:00 ET
  • 36.210
  • 0.0000.00%
Post 16:20 ET
730.11MMarket Cap-3.55P/E (TTM)

Praxis Precision Medicines Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-18.55%-131.76M
-135.20%-56.12M
-18.46%-27.5M
12.61%-27.28M
36.50%-20.86M
39.94%-111.14M
17.17%-23.86M
48.32%-23.22M
45.44%-31.21M
39.30%-32.85M
Net income from continuing operations
-48.30%-182.82M
-118.32%-58.68M
-110.74%-51.91M
4.77%-32.68M
-5.60%-39.55M
42.40%-123.28M
34.72%-26.88M
43.95%-24.63M
43.00%-34.31M
45.49%-37.46M
Depreciation and amortization
-17.13%358K
-57.66%47K
-15.60%92K
0.94%107K
5.66%112K
3.10%432K
5.71%111K
6.86%109K
-10.92%106K
13.98%106K
Other non cash items
310.16%3.43M
11.47%243K
11.32%236K
11.65%230K
1,255.22%2.72M
11.30%837K
11.22%218K
11.58%212K
10.75%206K
11.67%201K
Change In working capital
177.83%10.92M
-61.88%-4.92M
392.59%13.66M
123.91%715K
144.03%1.47M
-687.87%-14.03M
-155.20%-3.04M
43.12%-4.67M
41.97%-2.99M
-154.92%-3.34M
-Change in prepaid assets
-221.46%-8.23M
-557.37%-8.79M
-44.60%1.82M
-114.72%-449K
-145.62%-808K
1,138.03%6.77M
24.85%-1.34M
104.93%3.29M
71.12%3.05M
266.92%1.77M
-Change in payables and accrued expense
231.53%22.82M
707.89%5.62M
271.71%12.42M
135.94%1.8M
171.25%2.98M
-163.99%-17.35M
-136.76%-925K
24.53%-7.23M
24.20%-5.01M
-158.89%-4.18M
-Change in other current liabilities
-12.04%-1.13M
-11.49%-291K
-12.60%-286K
-11.20%-278K
-12.92%-271K
-23.92%-1.01M
-12.02%-261K
-12.39%-254K
23.31%-250K
-823.08%-240K
-Change in other working capital
-4.25%-2.55M
-183.69%-1.46M
36.32%-298K
54.03%-359K
36.60%-433K
-148.40%-2.45M
-110.30%-515K
---468K
---781K
-1,319.64%-683K
Cash from discontinued investing activities
Operating cash flow
-18.55%-131.76M
-135.20%-56.12M
-18.46%-27.5M
12.61%-27.28M
36.50%-20.86M
39.94%-111.14M
17.17%-23.86M
48.32%-23.22M
45.44%-31.21M
39.30%-32.85M
Investing cash flow
Cash flow from continuing investing activities
-737.98%-248.49M
-21,736.00%-10.92M
49.57M
-4,018.44%-195.92M
-368.29%-91.22M
-59.80%38.95M
-100.22%-50K
0
-85.67%5M
497.66%34M
Net PPE purchase and sale
--0
----
----
----
----
88.74%-50K
----
----
----
----
Net investment purchase and sale
-737.16%-248.49M
---10.92M
--49.57M
-4,018.44%-195.92M
-368.29%-91.22M
-59.93%39M
--0
--0
-85.71%5M
511.57%34M
Cash from discontinued investing activities
Investing cash flow
-737.98%-248.49M
-21,736.00%-10.92M
--49.57M
-4,018.44%-195.92M
-368.29%-91.22M
-59.80%38.95M
-100.22%-50K
--0
-85.67%5M
497.66%34M
Financing cash flow
Cash flow from continuing financing activities
459.83%514.32M
2,657.32%113.77M
1.44M
210.53%216.36M
911.38%182.76M
777.89%91.87M
-23.41%4.13M
0
13,724.40%69.68M
1,394.62%18.07M
Net common stock issuance
459.00%512M
2,681.37%111.95M
--1.24M
211.01%216.06M
909.90%182.75M
857.98%91.59M
-23.05%4.03M
--0
--69.47M
1,222.81%18.1M
Proceeds from stock option exercised by employees
532.93%2.63M
1,762.26%1.97M
20,000.00%201K
51.44%315K
41.58%143K
-70.83%416K
-34.97%106K
-99.76%1K
-60.00%208K
-69.67%101K
Net other financing activities
-124.82%-308K
-3,040.00%-157K
0.00%-1K
-225.00%-13K
-7.87%-137K
73.75%-137K
28.57%-5K
85.71%-1K
75.00%-4K
74.19%-127K
Cash from discontinued financing activities
Financing cash flow
459.83%514.32M
2,657.32%113.77M
--1.44M
210.53%216.36M
911.38%182.76M
777.89%91.87M
-23.41%4.13M
--0
13,724.40%69.68M
1,394.62%18.07M
Net cash flow
Beginning cash position
31.73%81.72M
66.56%169.06M
16.71%145.56M
87.55%152.4M
31.73%81.72M
-55.60%62.03M
61.48%101.5M
120.91%124.72M
3.81%81.26M
-55.60%62.03M
Current changes in cash
581.09%134.07M
336.17%46.73M
201.24%23.5M
-115.73%-6.84M
267.67%70.68M
125.34%19.69M
-2,298.18%-19.79M
-462.68%-23.22M
299.23%43.46M
131.28%19.22M
End cash Position
164.07%215.79M
164.07%215.79M
66.56%169.06M
16.71%145.56M
87.55%152.4M
31.73%81.72M
31.73%81.72M
61.48%101.5M
120.91%124.72M
3.81%81.26M
Free cash flow
-18.50%-131.76M
-134.71%-56.12M
-18.46%-27.5M
12.61%-27.28M
36.50%-20.86M
40.06%-111.19M
16.99%-23.91M
48.37%-23.22M
45.54%-31.21M
39.62%-32.85M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -18.55%-131.76M-135.20%-56.12M-18.46%-27.5M12.61%-27.28M36.50%-20.86M39.94%-111.14M17.17%-23.86M48.32%-23.22M45.44%-31.21M39.30%-32.85M
Net income from continuing operations -48.30%-182.82M-118.32%-58.68M-110.74%-51.91M4.77%-32.68M-5.60%-39.55M42.40%-123.28M34.72%-26.88M43.95%-24.63M43.00%-34.31M45.49%-37.46M
Depreciation and amortization -17.13%358K-57.66%47K-15.60%92K0.94%107K5.66%112K3.10%432K5.71%111K6.86%109K-10.92%106K13.98%106K
Other non cash items 310.16%3.43M11.47%243K11.32%236K11.65%230K1,255.22%2.72M11.30%837K11.22%218K11.58%212K10.75%206K11.67%201K
Change In working capital 177.83%10.92M-61.88%-4.92M392.59%13.66M123.91%715K144.03%1.47M-687.87%-14.03M-155.20%-3.04M43.12%-4.67M41.97%-2.99M-154.92%-3.34M
-Change in prepaid assets -221.46%-8.23M-557.37%-8.79M-44.60%1.82M-114.72%-449K-145.62%-808K1,138.03%6.77M24.85%-1.34M104.93%3.29M71.12%3.05M266.92%1.77M
-Change in payables and accrued expense 231.53%22.82M707.89%5.62M271.71%12.42M135.94%1.8M171.25%2.98M-163.99%-17.35M-136.76%-925K24.53%-7.23M24.20%-5.01M-158.89%-4.18M
-Change in other current liabilities -12.04%-1.13M-11.49%-291K-12.60%-286K-11.20%-278K-12.92%-271K-23.92%-1.01M-12.02%-261K-12.39%-254K23.31%-250K-823.08%-240K
-Change in other working capital -4.25%-2.55M-183.69%-1.46M36.32%-298K54.03%-359K36.60%-433K-148.40%-2.45M-110.30%-515K---468K---781K-1,319.64%-683K
Cash from discontinued investing activities
Operating cash flow -18.55%-131.76M-135.20%-56.12M-18.46%-27.5M12.61%-27.28M36.50%-20.86M39.94%-111.14M17.17%-23.86M48.32%-23.22M45.44%-31.21M39.30%-32.85M
Investing cash flow
Cash flow from continuing investing activities -737.98%-248.49M-21,736.00%-10.92M49.57M-4,018.44%-195.92M-368.29%-91.22M-59.80%38.95M-100.22%-50K0-85.67%5M497.66%34M
Net PPE purchase and sale --0----------------88.74%-50K----------------
Net investment purchase and sale -737.16%-248.49M---10.92M--49.57M-4,018.44%-195.92M-368.29%-91.22M-59.93%39M--0--0-85.71%5M511.57%34M
Cash from discontinued investing activities
Investing cash flow -737.98%-248.49M-21,736.00%-10.92M--49.57M-4,018.44%-195.92M-368.29%-91.22M-59.80%38.95M-100.22%-50K--0-85.67%5M497.66%34M
Financing cash flow
Cash flow from continuing financing activities 459.83%514.32M2,657.32%113.77M1.44M210.53%216.36M911.38%182.76M777.89%91.87M-23.41%4.13M013,724.40%69.68M1,394.62%18.07M
Net common stock issuance 459.00%512M2,681.37%111.95M--1.24M211.01%216.06M909.90%182.75M857.98%91.59M-23.05%4.03M--0--69.47M1,222.81%18.1M
Proceeds from stock option exercised by employees 532.93%2.63M1,762.26%1.97M20,000.00%201K51.44%315K41.58%143K-70.83%416K-34.97%106K-99.76%1K-60.00%208K-69.67%101K
Net other financing activities -124.82%-308K-3,040.00%-157K0.00%-1K-225.00%-13K-7.87%-137K73.75%-137K28.57%-5K85.71%-1K75.00%-4K74.19%-127K
Cash from discontinued financing activities
Financing cash flow 459.83%514.32M2,657.32%113.77M--1.44M210.53%216.36M911.38%182.76M777.89%91.87M-23.41%4.13M--013,724.40%69.68M1,394.62%18.07M
Net cash flow
Beginning cash position 31.73%81.72M66.56%169.06M16.71%145.56M87.55%152.4M31.73%81.72M-55.60%62.03M61.48%101.5M120.91%124.72M3.81%81.26M-55.60%62.03M
Current changes in cash 581.09%134.07M336.17%46.73M201.24%23.5M-115.73%-6.84M267.67%70.68M125.34%19.69M-2,298.18%-19.79M-462.68%-23.22M299.23%43.46M131.28%19.22M
End cash Position 164.07%215.79M164.07%215.79M66.56%169.06M16.71%145.56M87.55%152.4M31.73%81.72M31.73%81.72M61.48%101.5M120.91%124.72M3.81%81.26M
Free cash flow -18.50%-131.76M-134.71%-56.12M-18.46%-27.5M12.61%-27.28M36.50%-20.86M40.06%-111.19M16.99%-23.91M48.37%-23.22M45.54%-31.21M39.62%-32.85M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion--------
Trending Stocks
Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

Symbol Mini Chart % Chg
Lantheus
LNTH
+3.45%
Collegium Pharmaceutical
COLL
+2.59%
Constellation Brands
STZ
+1.73%
Halozyme Therapeutics
HALO
+0.75%
AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
AIPUY
0.00%

Unlock the Full List